HIGHLIGHT: KENTUCKY
Frankfort: Citing a national shortage of a drug increasingly used to treat COVID-19 patients, Gov. Andy Beshear announced Tuesday that the federal government is going to cap the supply to states, which will dole the monoclonal antibody treatment out to health care providers. The Democratic governor said he worries too many Kentuckians will rely on the Regeneron drug instead of a COVID-19 shot. “What this shortage ought to tell you is that if you’re unvaccinated, and you get really sick, not only might there not be a bed in the hospital for you because they are so full, but that monoclonal antibody treatment might not be there for you, either,” Beshear said.